Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer.
Bekric, D; Neureiter, D; Ablinger, C; Dobias, H; Beyreis, M; Ritter, M; Jakab, M; Bischof, J; Koller, U; Kiesslich, T; Mayr, C;
Cancers (Basel). 2023; 15(5):
Originalarbeiten (Zeitschrift)

The Cancer Stem Cell Inhibitor Napabucasin (BBI608) Shows General Cytotoxicity in Biliary Tract Cancer Cells and Reduces Cancer Stem Cell Characteristics.
Beyreis, M; Gaisberger, M; Jakab, M; Neureiter, D; Helm, K; Ritter, M; Kiesslich, T; Mayr, C;
Cancers (Basel). 2019; 11(3):
Originalarbeiten (Zeitschrift)

Miniaturization of the Clonogenic Assay Using Confluence Measurement.
Mayr, C; Beyreis, M; Dobias, H; Gaisberger, M; Pichler, M; Ritter, M; Jakab, M; Neureiter, D; Kiesslich, T;
Int J Mol Sci. 2018; 19(3):
Originalarbeiten (Zeitschrift)